Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.
2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10
52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,817 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,06,59351.5% delivered
Wockhardt has 1,014 announcements on record, routine notices left out; 6 in the 30 days to 3 Nov 2026, the latest on 2 Nov 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Wockhardt quarterly results
Nov2Mon
The board met on 2 Nov 2026 to consider financial results
Notice filed 27 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Wockhardt annual reports, presentations and earnings calls
The company's own documents, latest first.Wockhardt financials, year by year
Annual reports17
- Annual report, year to Mar 202617 Jul 2026
- Annual report, year to Mar 202516 Jul 2025
- Annual report, year to Mar 20246 Jun 2024
- Annual report, year to Mar 202321 Jul 2023, a zip file
- Annual report, year to Mar 202220 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20219 Jul 2021, a zip file
- Annual report, year to Mar 20206 Jul 2020, a zip file
- Annual report, year to Mar 201917 Jul 2019, a zip file
- Annual report, year to Mar 20185 Aug 2018, a zip file
- Annual report, year to Mar 20174 Aug 2017, a zip file
- Annual report, year to Mar 201616 Aug 2016, a zip file
- Annual report, year to Mar 201514 Aug 2015, a zip file
- Annual report, year to Mar 201421 Aug 2014, a zip file
- Annual report, year to Mar 201320 Aug 2013, a zip file
- Annual report, year to Mar 201218 Sep 2012, a zip file
- Annual report, year to Mar 201116 Sep 2011, a zip file
- Annual report, year to Mar 201014 Sep 2010, a zip file
Investor presentations7
- Investor Presentation4 Jun 2026
- Investor Presentation5 Jun 2025
- Investor Presentation5 Jun 2025
- Company will hold an Investor meet/call on Thursday, 5th June, 2025 at 11:00 hrs IST through VC and in-person as detailed in the enclosed invite. The meeting/call will be initiated with a presentation by Dr. Murtaza Khorakiwala, Managing Director and will be followed by a Q&A Session in presence of Dr. Habil Khorakiwala, Chairman.2 Jun 2025
- Investor Presentation26 Feb 2024
2 earlier presentations
- Investor Presentation21 Feb 2023
- Investor Presentation8 Mar 2022
Earnings calls3
- And in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2025-26/015 dated 1st June, 2026, please find enclosed the transcript of the Investor Meeting held on Thursday, 4th June, 2026, for your information and records.11 Jun 2026
- Transcript11 Jun 2025
- Transcript of the Investor Call held on February 21, 2023.24 Feb 2023
Wockhardt merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings2
- Hon'ble High Court of Bombay on March 20, 2015 sanctioned the Scheme of Amalgamation of two wholly owned subsidiaries viz. Wockhardt Biopharm Limited and Vinton Healthcare Limited with Wockhardt Limited ("the Company"). The appointed date of the said scheme of amalgamation is April 1, 2014. The aforesaid scheme will be effective once the order of the High Court is filed with Registrar of Companies, Mumbai.23 Mar 2015, a zip file
- Board Meeting of the Company at its meeting held on September 15, 2014 inter-alia approved a scheme of Amalgamation for amalgamation/merger of following two wholly owned subsidiaries with the Company : 1) Wockhardt Biopharm Limited 2) Vinton Healthcare Limited. Furher, as mentioned above, since WBL & VHL are wholly owned subsidiaries of the Company, no shares are proposed to be issued pursuant to the amalgamation. This scheme is subject to requisite approvals, including under Listing Agreement and by the Hon'ble High Courts. The amalgamation being of wholly owned subsidiaries into the Company, a specific dispensation will be sought from the Hon'ble High Courts from filing the application/petition by the Company and accordingly, the Company may not be required to file petition with the High Court.16 Sep 2014, a zip file
Wockhardt share news and announcements
Newest first. Page 1 of 21.
Nov 2026
Oct 2026
27 Oct · Board meeting
Aug 2026
Jul 2026
Jun 2026
May 2026
21 May · Rating
Apr 2026
Mar 2026
Feb 2026
Jan 2026
Dec 2025
2 Dec · Reply To Email Related To Volume Movement
Nov 2025
3 Nov · Results
Oct 2025
Sep 2025
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 10 Aug 2026Resultsdown 4.44%−4.6 pts vs Nifty 500market median −0.7% · five sessions −4.4% (−3.9 pts vs Nifty 500) · volume 2.7× usual · delivery −9.2 pts against usual · The announcement
- 21 May 2026Credit ratingdown 0.75%−0.9 pts vs Nifty 500market median 0.0% · five sessions +9.9% (+8.1 pts vs Nifty 500) · volume 0.3× usual · delivery +1.3 pts against usual · The announcement
- 5 May 2026Resultsup 7.86%+8.0 pts vs Nifty 500market median −0.7% · five sessions +14.1% (+14.2 pts vs Nifty 500) · volume 27.4× usual · delivery −31.0 pts against usual · The announcement
- 5 May 2026Board or managers changedup 7.86%+8.0 pts vs Nifty 500market median 0.0% · five sessions +14.1% (+14.2 pts vs Nifty 500) · volume 27.4× usual · delivery −31.0 pts against usual · The announcement
- 10 Feb 2026Resultsup 1.27%+1.0 pts vs Nifty 500market median −0.7% · five sessions −1.5% (−0.6 pts vs Nifty 500) · volume 4.8× usual · delivery −14.2 pts against usual · The announcement
- 4 Feb 2026Board or managers changedup 4.33%+3.9 pts vs Nifty 500market median 0.0% · five sessions +5.9% (+4.5 pts vs Nifty 500) · volume 1.5× usual · delivery −1.4 pts against usual · The announcement
- 3 Nov 2025Resultsup 10.32%+9.9 pts vs Nifty 500market median −0.7% · five sessions +6.2% (+6.7 pts vs Nifty 500) · volume 19.4× usual · delivery −33.3 pts against usual · The announcement
- 28 Aug 2025Credit ratingdown 2.99%−2.0 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+0.8 pts vs Nifty 500) · volume 0.7× usual · delivery −1.3 pts against usual · The announcement
- 8 Aug 2025Resultsdown 3.25%−2.1 pts vs Nifty 500market median −0.7% · five sessions +0.2% (+0.3 pts vs Nifty 500) · volume 1.4× usual · delivery −8.8 pts against usual · The announcement
- 29 May 2025Resultsup 0.73%+0.4 pts vs Nifty 500market median −0.7% · five sessions +11.6% (+11.5 pts vs Nifty 500) · volume 1.3× usual · delivery −10.8 pts against usual · The announcement
20 earlier announcements
- 1 Oct 2024Board or managers changeddown 0.98%−1.1 pts vs Nifty 500market median 0.0% · five sessions −2.2% (+0.8 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 9 Aug 2024Resultsup 3.77%+2.8 pts vs Nifty 500market median −0.7% · five sessions +1.7% (+0.2 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 6 Aug 2024Board or managers changeddown 2.53%−2.1 pts vs Nifty 500market median 0.0% · five sessions +13.3% (+11.7 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 8 Jul 2024Board or managers changeddown 3.11%−3.0 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−6.1 pts vs Nifty 500) · volume 0.7× usual · delivery −10.9 pts against usual · The announcement
- 10 Jun 2024Board or managers changeddown 0.35%−0.6 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−2.4 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 29 May 2024Resultsup 0.56%+1.2 pts vs Nifty 500market median −0.7% · five sessions −8.1% (−3.2 pts vs Nifty 500) · volume 2.2× usual · The announcement
- 16 May 2024Credit ratingup 0.98%+0.1 pts vs Nifty 500market median 0.0% · five sessions −0.2% (−2.6 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 4 Apr 2024Board or managers changeddown 0.44%−0.7 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−3.7 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 3 Apr 2024Board or managers changeddown 1.85%−2.0 pts vs Nifty 500market median 0.0% · five sessions −1.0% (−2.1 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 15 Feb 2024Resultsdown 0.96%−1.5 pts vs Nifty 500market median −0.7% · five sessions +25.5% (+24.5 pts vs Nifty 500) · volume 0.6× usual · delivery +2.9 pts against usual · The announcement
- 15 Nov 2023Resultsdown 1.47%−2.6 pts vs Nifty 500market median −0.7% · five sessions +18.4% (+16.7 pts vs Nifty 500) · volume 4.6× usual · delivery −7.5 pts against usual · The announcement
- 5 Sep 2023Credit ratingup 1.22%+0.8 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+2.2 pts vs Nifty 500) · volume 0.8× usual · delivery −4.2 pts against usual · The announcement
- 14 Aug 2023Resultsdown 4.24%−4.0 pts vs Nifty 500market median −0.7% · five sessions −8.9% (−8.9 pts vs Nifty 500) · volume 1.1× usual · delivery −3.4 pts against usual · The announcement
- 19 Jul 2023Board or managers changeddown 1.72%−2.2 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−2.2 pts vs Nifty 500) · volume 0.3× usual · delivery +6.1 pts against usual · The announcement
- 8 Jun 2023Credit ratingup 1.03%+1.6 pts vs Nifty 500market median 0.0% · five sessions +10.8% (+10.4 pts vs Nifty 500) · volume 2.5× usual · delivery −14.8 pts against usual · The announcement
- 29 May 2023Resultsdown 1.71%−2.2 pts vs Nifty 500market median −0.7% · five sessions −2.2% (−2.9 pts vs Nifty 500) · volume 0.6× usual · delivery +8.2 pts against usual · The announcement
- 23 Dec 2022Credit ratingdown 5.48%−3.0 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−5.3 pts vs Nifty 500) · volume 2.5× usual · delivery −7.0 pts against usual · The announcement
- 4 Nov 2022Resultsdown 0.93%−1.2 pts vs Nifty 500market median −0.7% · five sessions −6.6% (−7.7 pts vs Nifty 500) · volume 2.9× usual · delivery −17.2 pts against usual · The announcement
- 5 Sep 2022Credit ratingup 3.01%+2.4 pts vs Nifty 500market median 0.0% · five sessions +10.6% (+8.9 pts vs Nifty 500) · volume 2.6× usual · delivery +17.4 pts against usual · The announcement
- 16 Aug 2022Resultsdown 2.35%−3.3 pts vs Nifty 500market median −0.7% · five sessions +9.8% (+10.7 pts vs Nifty 500) · volume 1.1× usual · delivery +1.7 pts against usual · The announcement
Wockhardt results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.